RINVOQ tablets 15mg (Upadacitinib hydrate), manufactured by AbbVie (YJ code: 3999048G2024, standard: 15mg 1 tablet), is a Janus kinase (JAK) inhibitor used to treat a range of inflammatory conditions. These include moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, ulcerative colitis, and Crohn’s disease in eligible adult and pediatric patients.
RINVOQ tablets 15mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
